Ardelyx Receives $30,000,000 Series B Round
Aug 31, 2011 • Deals • TechZulu Inc.
| Company Name | Ardelyx |
| Information Release Date | 8/31/2011 |
| Transaction Type | Venture Equity |
| Amount | $30,000,000 |
| Round | Series B |
| Proceeds Purpose | The proceeds of the financing will be used to advance Ardelyx’s pipeline that includes three product candidates: a clinical stage product, RDX5791, being evaluated in constipation-predominant irritable bowel syndrome (IBS-C) and in the prevention of excess dietary sodium absorption, and two preclinical products, RDX002 in chronic kidney disease and RDX009 in type 2 diabetes. |
